Compugen Ltd. (CGEN) Q2 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Compugen Ltd..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.000 -- 00:00:05.840 Welcome to the ComputeGen LTD Second Quarter 2025 Financial 00:00:05.840 -- 00:00:11.160 Results Conference Call. At this time, all participants are in 00:00:11.160 -- 00:00:16.220 a listen-only mode. An audio webcast of this call is available 00:00:16.220 -- 00:00:20.100 in the Investments section of ComputeGen's website 00:00:20.100 -- 00:00:21.360 www 00:00:21.360 -- 00:00:23.360 .cgen.com. 00:00:24.460 -- 00:00:28.680 As a reminder, today's call is being recorded. 00:00:28.680 -- 00:00:33.000 I would now like to introduce Yvonne Mocklin, Vice 00:00:33.000 -- 00:00:38.700 President, Head of Investor Relations and Corporate Communications. 00:00:38.700 -- 00:00:41.980 Thank you, Operator, and thank you all for joining us on the call today. 00:00:41.980 -- 00:00:47.900 Joining me from ComputeGen is Dr. Anath Kholen-Diark, Head of the Chief Executive Officer, 00:00:47.900 -- 00:00:50.760 and David Sivaman, Chief Financial Officer. 00:00:50.760 -- 00:00:53.540 Dr. Michelle Morer, Chief Medical Officer, and Dr. 00:00:53.540 -- 00:00:57.660 Alana Lofair, Chief Scientific Officer, will join us with the Q&A. 00:00:57.660 -- 00:01:01.700 Before we begin, we would like to remind you that during this call, the company will 00:01:01.700 -- 00:01:06.500 make projections of forward-looking statements regarding future events, business outlook, 00:01:06.500 -- 00:01:11.060 development efforts and their potential outcome, the company's discovery platform, anticipated 00:01:11.060 -- 00:01:15.780 progress and plans, results and timelines for our programs, financial and accounting 00:01:15.780 -- 00:01:21.260 related matters, as well as statements regarding our cash petition and cash runway. 00:01:21.260 -- 00:01:25.400 We reached a call from you ...